CTTNBP2 and neuroblastoma: Overall, these findings provide strong evidence supporting the role of CTTNBP2 and MCF2L in NB tumorigenesis, suggesting that their reduced expression contributes to the development and progression of more aggressive and high-risk NB phenotypes.